QIAGEN NV

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL0015001WM6
USD
36.95
0.37 (1.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
492.32
540.42
532.58
533.54
483.46
521.20
501.87
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
492.32
540.42
532.58
533.54
483.46
521.20
501.87
Raw Material Cost
184.45
217.43
203.44
201.07
175.25
186.41
187.33
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.05
10.14
8.22
7.61
7.29
11.14
11.48
Selling and Distribution Expenses
142.39
153.88
143.11
148.75
137.94
141.71
140.66
Other Expenses
3.72
3.71
4.05
4.01
3.65
3.75
3.30
Total Expenditure (Excl Depreciation)
375.10
418.54
395.29
397.57
356.98
376.73
372.44
Operating Profit (PBDIT) excl Other Income
117.2
121.89999999999999
137.3
136
126.5
144.5
129.4
Other Income
13.33
20.10
14.80
12.52
8.33
26.87
18.39
Operating Profit (PBDIT)
181.77
191.37
203.06
197.98
178.72
216.90
197.80
Interest
11.05
10.14
8.22
7.61
7.29
11.14
11.48
Exceptional Items
-33.67
-22.67
-9.15
-14.07
-7.97
-34.35
-19.87
Gross Profit (PBDT)
307.87
322.99
329.15
332.47
308.20
334.79
314.54
Depreciation
51.21
49.39
50.97
49.48
43.91
45.55
49.99
Profit Before Tax
85.83
109.17
134.73
126.82
119.55
125.85
116.46
Tax
17.79
1.34
4.68
30.57
28.79
37.53
18.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
68.04
107.83
130.04
96.25
90.76
88.32
98.06
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
68.04
107.83
130.04
96.25
90.76
88.32
98.06
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
68.04
107.83
130.04
96.25
90.76
88.32
98.06
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.01
Reserves
3,331.71
3,778.15
3,649.41
3,505.49
3,407.88
3,567.34
3,529.99
Earnings per share (EPS)
0.33
0.52
0.63
0.46
0.43
0.43
0.47
Diluted Earnings per share
0.33
0.52
0.63
0.46
0.43
0.43
0.47
Operating Profit Margin (Excl OI)
23.81%
22.55%
25.78%
25.49%
26.16%
27.72%
25.79%
Gross Profit Margin
27.84%
29.34%
34.87%
33.04%
33.81%
32.89%
33.17%
PAT Margin
13.82%
19.95%
24.42%
18.04%
18.77%
16.95%
19.54%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -8.90% vs 1.46% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -36.92% vs -17.08% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -1.69% vs -9.03% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 9.90% vs 23.17% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of QIAGEN NV With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
492.32
823.40
-331.08
-40.21%
Other Operating Income
0.00
0.00
0.00
Total Operating income
492.32
823.40
-331.08
-40.21%
Raw Material Cost
184.45
434.10
-249.65
-57.51%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
11.05
12.20
-1.15
-9.43%
Selling and Distribution Expenses
142.39
242.10
-99.71
-41.19%
Other Expenses
3.72
8.91
-5.19
-58.25%
Total Expenditure (Excl Depreciation)
375.10
777.50
-402.40
-51.76%
Operating Profit (PBDIT) excl Other Income
117.22
45.90
71.32
155.38%
Other Income
13.33
22.80
-9.47
-41.54%
Operating Profit (PBDIT)
181.77
126.10
55.67
44.15%
Interest
11.05
12.20
-1.15
-9.43%
Exceptional Items
-33.67
-33.70
0.03
0.09%
Gross Profit (PBDT)
307.87
389.30
-81.43
-20.92%
Depreciation
51.21
58.30
-7.09
-12.16%
Profit Before Tax
85.83
21.90
63.93
291.92%
Tax
17.79
2.50
15.29
611.60%
Provisions and contingencies
0
0
0.00
Profit After Tax
68.04
14.40
53.64
372.50%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
68.04
14.40
53.64
372.50%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
1.30
-1.30
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
68.04
15.70
52.34
333.38%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
3,331.71
2,449.10
882.61
36.04%
Earnings per share (EPS)
0.33
0.02
0.31
1,550.00%
Diluted Earnings per share
0.33
0.02
0.31
1,550.00%
Operating Profit Margin (Excl OI)
23.81%
5.47%
0.00
18.34%
Gross Profit Margin
27.84%
9.74%
0.00
18.10%
PAT Margin
13.82%
1.75%
0.00
12.07%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 49.23 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -8.90% vs 1.46% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 1.82% vs 5.38% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.80 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -36.92% vs -17.08% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -25.11% vs 12.52% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.84 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -1.69% vs -9.03% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -1.17% vs 11.66% in Mar 2025

Quarterly - Interest
Interest 1.11 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 9.90% vs 23.17% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 52.05% vs -29.13% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.81%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025